National and Kapodistrian University of Athens
Μελέτη βιολογικών δεικτών σε πάσχοντες από μακροσφαιριναιμία Waldenstrom
Abstract
dc:descriptionLiquid biopsy is being integrated into cancer diagnostics with profound therapeutic implications. However, its role in Waldenström’s Macroglobulinemia (WM) and IgM monoclonal gammopathies is still unclear. In this study, we evaluated the role of peripheral blood cell-free DNA (cfDNA) in characterizing the mutational status of MYD88 and CXCR4 of patients with IgM monoclonal gammopathies. Paired bone marrow tumor DNA (tDNA) and peripheral blood cfDNA samples from 207 patients (40 MGUS, 47 with WM in remission, 103 with smoldering WM, newly diagnosed or relapsed WM) and 10 controls with non-IgM monoclonal gammopathies were analyzed. Regarding MYD88L265P mutation, 150 patients had paired tDNA and cfDNA informative samples. The overall concordance rate was 97% (145/150) (p<0.001). Similar concordance rates were detected among disease subgroups. For CXCR4 mutations, 131 patients had paired informative tDNA and cfDNA samples. The overall concordance rate was 84% (110/131) (p<0.001). The corresponding concordance rates among disease subgroups were similar. All controls were wild-type for MYD88 and CXCR4. In conclusion, peripheral blood cfDNA is a useful, minimally invasive, cost effective and time-effective tool for the identification of the presence of MYD88 and CXCR4 mutations in patients with IgM monoclonal gammopathies avoiding unnecessary bone marrow assessment.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2020
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Ntanasis-Stathopoulos, Ioannis
- Ντάνασης-Σταθόπουλος, Ιωάννης
Subjects
dc:subject × 12Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/47269